For citations:
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus. Diabetes mellitus. 2012;15(2):103-104. (In Russ.) https://doi.org/10.14341/2072-0351-5527

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).